{
    "title": "US FDA panel backs accelerated approval for Biogen's ALS drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11892049/US-FDA-panel-votes-against-effectiveness-Biogens-ALS-drug.html",
    "date": "2023-03-22",
    "keywords": [
        "approval",
        "drug",
        "panel",
        "biogen",
        "disease",
        "evidence",
        "tofersen",
        "protein",
        "neurofilament",
        "fda",
        "vote",
        "bhanvi",
        "regulator",
        "treatment",
        "lou",
        "gehrigs",
        "way",
        "favor",
        "disorder",
        "marker",
        "nerve",
        "cell",
        "degeneration",
        "latestage",
        "study",
        "goal",
        "food",
        "administration",
        "analyst",
        "marc",
        "advise",
        "convincing",
        "effectiveness",
        "panelist",
        "robert",
        "neurologist",
        "agencys",
        "pathway",
        "trial",
        "benefit",
        "market",
        "sclerosis",
        "paralysis",
        "death",
        "cause",
        "partner",
        "gene",
        "buildup",
        "dismutase",
        "reporting",
        "satija",
        "raghav",
        "mahobe",
        "bengaluru",
        "editing",
        "dasgupta",
        "saumyadeb",
        "chakrabarty"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}